Toward realization of ‘mix-and-use’ approach in 68 Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of 68 Ga-labeled NODAGA-coupled RGD peptide derivative
Sudipta Chakraborty, Ashutosh Dash(Bhabha Atomic Research Centre), Rakhee Vatsa(Post Graduate Institute of Medical Education and Research), Haladhar Dev Sarma(Bhabha Atomic Research Centre), Bhagwant Rai Mittal(Government of Haryana), Rubel Chakravarty(Bhabha Atomic Research Centre), Priya Bhusari(Post Graduate Institute of Medical Education and Research), Jaya Shukla(Rutgers, The State University of New Jersey)
Cited by 11
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
|Nuclear Medicine and Biology|2008|99